Procept Biorobotics Corp Stock Market Value
| PRCT Stock | USD 27.79 0.30 1.07% |
| Symbol | Procept |
Is there potential for Health Care Equipment & Supplies market expansion? Will Procept introduce new products? Factors like these will boost the valuation of Procept Biorobotics. Anticipated expansion of Procept directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Procept Biorobotics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.53) | Revenue Per Share | Quarterly Revenue Growth 0.428 | Return On Assets | Return On Equity |
Understanding Procept Biorobotics Corp requires distinguishing between market price and book value, where the latter reflects Procept's accounting equity. The concept of intrinsic value - what Procept Biorobotics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Procept Biorobotics' price substantially above or below its fundamental value.
It's important to distinguish between Procept Biorobotics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Procept Biorobotics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Procept Biorobotics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Procept Biorobotics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Procept Biorobotics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Procept Biorobotics.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Procept Biorobotics on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Procept Biorobotics Corp or generate 0.0% return on investment in Procept Biorobotics over 90 days. Procept Biorobotics is related to or competes with Twist Bioscience, Guardian Pharmacy, Mesoblast, Qilian International, Quidel, Edgewise Therapeutics, and Clover Health. PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology More
Procept Biorobotics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Procept Biorobotics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Procept Biorobotics Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 17.65 | |||
| Value At Risk | (5.10) | |||
| Potential Upside | 7.06 |
Procept Biorobotics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Procept Biorobotics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Procept Biorobotics' standard deviation. In reality, there are many statistical measures that can use Procept Biorobotics historical prices to predict the future Procept Biorobotics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.05) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Procept Biorobotics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Procept Biorobotics February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.04) | |||
| Mean Deviation | 2.64 | |||
| Coefficient Of Variation | (3,529) | |||
| Standard Deviation | 3.57 | |||
| Variance | 12.75 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.05) | |||
| Maximum Drawdown | 17.65 | |||
| Value At Risk | (5.10) | |||
| Potential Upside | 7.06 | |||
| Skewness | 1.09 | |||
| Kurtosis | 1.57 |
Procept Biorobotics Corp Backtested Returns
Currently, Procept Biorobotics Corp is not too volatile. Procept Biorobotics Corp maintains Sharpe Ratio (i.e., Efficiency) of 0.0155, which implies the firm had a 0.0155 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Procept Biorobotics Corp, which you can use to evaluate the volatility of the company. Please check Procept Biorobotics' Variance of 12.75, coefficient of variation of (3,529), and Risk Adjusted Performance of (0.02) to confirm if the risk estimate we provide is consistent with the expected return of 0.0572%. Procept Biorobotics has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of 2.06, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Procept Biorobotics will likely underperform. Procept Biorobotics Corp right now holds a risk of 3.69%. Please check Procept Biorobotics Corp treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Procept Biorobotics Corp will be following its historical price patterns.
Auto-correlation | -0.48 |
Modest reverse predictability
Procept Biorobotics Corp has modest reverse predictability. Overlapping area represents the amount of predictability between Procept Biorobotics time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Procept Biorobotics Corp price movement. The serial correlation of -0.48 indicates that about 48.0% of current Procept Biorobotics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.48 | |
| Spearman Rank Test | -0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 3.66 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.